These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

992 related articles for article (PubMed ID: 33566076)

  • 1. Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2.
    Zucman N; Uhel F; Descamps D; Roux D; Ricard JD
    Clin Infect Dis; 2021 Nov; 73(10):1945-1946. PubMed ID: 33566076
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.
    Wibmer CK; Ayres F; Hermanus T; Madzivhandila M; Kgagudi P; Oosthuysen B; Lambson BE; de Oliveira T; Vermeulen M; van der Berg K; Rossouw T; Boswell M; Ueckermann V; Meiring S; von Gottberg A; Cohen C; Morris L; Bhiman JN; Moore PL
    Nat Med; 2021 Apr; 27(4):622-625. PubMed ID: 33654292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.
    Barlev-Gross M; Weiss S; Paran N; Yahalom-Ronen Y; Israeli O; Nemet I; Kliker L; Zuckerman N; Glinert I; Noy-Porat T; Alcalay R; Rosenfeld R; Levy H; Mazor O; Mandelboim M; Mendelson E; Beth-Din A; Israely T; Mechaly A
    J Infect Dis; 2021 Aug; 224(4):616-619. PubMed ID: 34398244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary data on severe SARS-CoV-2 infection caused by the 501Y.V2 variant.
    Louis G; Goetz C; Mellati N; Dunand P; Picard Y
    Anaesth Crit Care Pain Med; 2021 Aug; 40(4):100890. PubMed ID: 34033926
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
    J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
    Teyssou E; Soulie C; Visseaux B; Lambert-Niclot S; Ferre V; Marot S; Jary A; Sayon S; Zafilaza K; Leducq V; Schnuriger A; Abdi B; Wirden M; Houhou-Fidouh N; Charpentier C; Morand-Joubert L; Burrel S; Descamps D; Calvez V; Marcelin AG
    J Infect; 2021 Jul; 83(1):119-145. PubMed ID: 33932451
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.
    Nonaka CKV; Franco MM; Gräf T; de Lorenzo Barcia CA; de Ávila Mendonça RN; de Sousa KAF; Neiva LMC; Fosenca V; Mendes AVA; de Aguiar RS; Giovanetti M; de Freitas Souza BS
    Emerg Infect Dis; 2021 May; 27(5):1522-1524. PubMed ID: 33605869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of patients with acute respiratory failure due to the SARS-CoV-2 501Y.V2 variant: a multicenter retrospective matched cohort study.
    Puech B; Legrand A; Simon O; Combe C; Jaffar-Bandjee MC; Caron M; Vidal C; Mavingui P; Blonde R; Boue Y; Berguigua H; Allyn J; Bruneau L; Ferdynus C; Allou N
    Sci Rep; 2022 May; 12(1):8747. PubMed ID: 35610307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.
    Tang JW; Toovey OTR; Harvey KN; Hui DDS
    J Infect; 2021 Apr; 82(4):e8-e10. PubMed ID: 33472093
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a multiplex RT-qPCR using the drop out strategy to screen the SARS-CoV-2 South African 501Y.V2 variant.
    Maclot F; Bontems S; Meex C; Artesi M; Beckers P; Bours V; Durkin K; Hayette MP
    J Infect; 2021 Jul; 83(1):e19-e21. PubMed ID: 33957162
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil.
    Fintelman-Rodrigues N; da Silva APD; Dos Santos MC; Saraiva FB; Ferreira MA; Gesto J; Rodrigues DAS; Vale AM; de Azevedo IG; Soares VC; Jiang H; Tan H; Tschoeke DA; Sacramento CQ; Bozza FA; Morel CM; Bozza PT; Souza TML
    Emerg Infect Dis; 2021 May; 27(5):1446-1453. PubMed ID: 33797393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.
    Tang X; Musa SS; Zhao S; He D
    Front Public Health; 2021; 9():663045. PubMed ID: 34178920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Early Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Larson D; Brodniak SL; Voegtly LJ; Cer RZ; Glang LA; Malagon FJ; Long KA; Potocki R; Smith DR; Lanteri C; Burgess T; Bishop-Lilly KA
    Clin Infect Dis; 2021 Nov; 73(9):e2827-e2828. PubMed ID: 32949240
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
    Abu-Raddad LJ; Chemaitelly H; Malek JA; Ahmed AA; Mohamoud YA; Younuskunju S; Ayoub HH; Al Kanaani Z; Al Khal A; Al Kuwari E; Butt AA; Coyle P; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Bertollini R
    Clin Infect Dis; 2021 Oct; 73(7):e1830-e1840. PubMed ID: 33315061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain.
    Van Elslande J; Vermeersch P; Vandervoort K; Wawina-Bokalanga T; Vanmechelen B; Wollants E; Laenen L; André E; Van Ranst M; Lagrou K; Maes P
    Clin Infect Dis; 2021 Jul; 73(2):354-356. PubMed ID: 32887979
    [No Abstract]   [Full Text] [Related]  

  • 16. Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection of a Healthcare Worker in a Belgian Nosocomial Outbreak Despite Primary Neutralizing Antibody Response.
    Selhorst P; van Ierssel SH; Michiels J; Mariën J; Bartholomeeusen K; Dirinck E; Vandamme S; Jansens H; Ariën KK
    Clin Infect Dis; 2021 Nov; 73(9):e2985-e2991. PubMed ID: 33315049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection.
    Dimeglio C; Herin F; Miedougé M; Martin-Blondel G; Soulat JM; Izopet J
    Clin Infect Dis; 2021 Oct; 73(7):1323-1324. PubMed ID: 33503228
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral Shedding among Re-Positive Severe Acute Respiratory Syndrome Coronavirus-2 Positive Individuals in Republic of Korea.
    Kim JM; Ryu B; Choe YJ; Jo HJ; Lee H; Kim HM; Lee NJ; Rhee JE; Chung YS; Han MG; Kim EJ; Park Y; Gwack J; Jin Y; Song J; Seo S; Gill B; Kim H; Park Y; Yoo CK; Jeong EK
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk.
    Murillo-Zamora E; Trujillo X; Huerta M; Ríos-Silva M; Aguilar-Sollano F; Mendoza-Cano O
    BMC Infect Dis; 2021 Sep; 21(1):923. PubMed ID: 34488661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
    Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
    EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.